MISTY HARRISON: Open Payments
NPI 1366535411 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 31 payments from 9 companies in 2025. Trend: 2023 $321 · 2024 $530 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 11 | $230 |
| Novo Nordisk Inc | 9 | $203 |
| Amgen Inc. | 3 | $69 |
| Medtronic, Inc. | 2 | $42 |
| Neurocrine BioSciences, Inc. | 1 | $34 |
| BETA BIONICS, INC. | 2 | $34 |
| Sequel Med Tech, LLC | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Acella Pharmaceuticals, LLC | 1 | $17 |
Products named: Ozempic, ESPRIT, FREESTYLE LIBRE 3, ULTREON, TEPEZZA, MINIMED 780G, CRENESSITY, iLet Bionic Pancreas.
Industry payments across TX — which companies pay providers there.
